Ophthotech Corp (NASDAQ:OPHT)

Data as of Sep 18
 -0.50 / -1.28%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Ophthotech Corp. operates as a development stage biopharmaceutical company. It focuses on discovering, developing and commercializing novel therapeutics to treat diseases of the eye. The company develops therapies for wet and dry age-related macular degeneration. Its product candidates include Fovista and ARC1905. The company was founded on January 5, 2007 by David R. Guyer and Samir Chandrakant Patel and is headquartered in New York, NY.

Contact Information

Ophthotech Corp.
One Penn Plaza
New York New York 10119
P:(212) 845-8200
Investor Relations:
(609) 945-6050



Individual stakeholders43.33%
Mutual fund holders34.51%
Other institutional13.51%

Top Executives

David R. GuyerChairman & Chief Executive Officer
Samir Chandrakant PatelVice Chairman & President
Evelyn M. HarrisonChief Operating Officer
Bruce A. PeacockCFO, Secretary, Treasurer & Chief Business Officer
Richard L. BeckmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.